Eli Lilly and Company

CDI - Pharmacien industriel 5x8- F/H

Fegersheim, Grand Est, France

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

The ideal candidate is a licensed Industrial Pharmacist (with thesis) or currently in the process of validation, possessing a Master's degree in Quality Assurance and/or Pharmaceutical Production and/or Pharmaceutical Engineering. They should have at least one year of professional experience in a pharmaceutical production environment, ideally within an international group, and demonstrate a B2 level of English proficiency.

Responsibilities

This role involves evaluating the quality of semi-finished batch dossiers and accepting lots, independently deciding on the continuation or cessation of production based on quality issues. The Pharmacien industriel will manage quality deviations, implement corrective action plans, evaluate the impact of equipment/process/process modifications, review and approve quality and technical documents, apply and enforce GMP requirements, provide quality support to internal teams, participate in projects and improvement actions, support the site during audits and inspections, and ensure pharmaceutical coverage for the site.

Skills

GMP
Quality Assurance
Pharmaceutical Production
Deviation Management
Corrective Action Plans
Audits
Regulatory Compliance
Technical Documents
Process Improvement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI